
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Phenotype and kinetics of SARS-CoV-2–specific T cells in COVID-19 patients with acute respiratory distress syndrome
Daniela Weiskopf, Katharina S. Schmitz, Matthijs P. Raadsen, et al.
Science Immunology (2020) Vol. 5, Iss. 48
Open Access | Times Cited: 954
Daniela Weiskopf, Katharina S. Schmitz, Matthijs P. Raadsen, et al.
Science Immunology (2020) Vol. 5, Iss. 48
Open Access | Times Cited: 954
Showing 1-25 of 954 citing articles:
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
Alba Grifoni, Daniela Weiskopf, Sydney I. Ramirez, et al.
Cell (2020) Vol. 181, Iss. 7, pp. 1489-1501.e15
Open Access | Times Cited: 3759
Alba Grifoni, Daniela Weiskopf, Sydney I. Ramirez, et al.
Cell (2020) Vol. 181, Iss. 7, pp. 1489-1501.e15
Open Access | Times Cited: 3759
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Pedro M. Folegatti, Katie Ewer, Parvinder K. Aley, et al.
The Lancet (2020) Vol. 396, Iss. 10249, pp. 467-478
Open Access | Times Cited: 2488
Pedro M. Folegatti, Katie Ewer, Parvinder K. Aley, et al.
The Lancet (2020) Vol. 396, Iss. 10249, pp. 467-478
Open Access | Times Cited: 2488
Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity
Carolyn Rydyznski Moderbacher, Sydney I. Ramirez, Jennifer M. Dan, et al.
Cell (2020) Vol. 183, Iss. 4, pp. 996-1012.e19
Open Access | Times Cited: 1793
Carolyn Rydyznski Moderbacher, Sydney I. Ramirez, Jennifer M. Dan, et al.
Cell (2020) Vol. 183, Iss. 4, pp. 996-1012.e19
Open Access | Times Cited: 1793
Adaptive immunity to SARS-CoV-2 and COVID-19
Alessandro Sette, Shane Crotty
Cell (2021) Vol. 184, Iss. 4, pp. 861-880
Open Access | Times Cited: 1749
Alessandro Sette, Shane Crotty
Cell (2021) Vol. 184, Iss. 4, pp. 861-880
Open Access | Times Cited: 1749
Immunology of COVID-19: Current State of the Science
Nicolas Vabret, Graham J. Britton, Conor Gruber, et al.
Immunity (2020) Vol. 52, Iss. 6, pp. 910-941
Open Access | Times Cited: 1656
Nicolas Vabret, Graham J. Britton, Conor Gruber, et al.
Immunity (2020) Vol. 52, Iss. 6, pp. 910-941
Open Access | Times Cited: 1656
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
Divij Mathew, Josephine R. Giles, Amy E. Baxter, et al.
Science (2020) Vol. 369, Iss. 6508
Open Access | Times Cited: 1536
Divij Mathew, Josephine R. Giles, Amy E. Baxter, et al.
Science (2020) Vol. 369, Iss. 6508
Open Access | Times Cited: 1536
Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans
José Mateus, Alba Grifoni, Alison Tarke, et al.
Science (2020) Vol. 370, Iss. 6512, pp. 89-94
Open Access | Times Cited: 1189
José Mateus, Alba Grifoni, Alison Tarke, et al.
Science (2020) Vol. 370, Iss. 6512, pp. 89-94
Open Access | Times Cited: 1189
The T cell immune response against SARS-CoV-2
Paul Moss
Nature Immunology (2022) Vol. 23, Iss. 2, pp. 186-193
Open Access | Times Cited: 1087
Paul Moss
Nature Immunology (2022) Vol. 23, Iss. 2, pp. 186-193
Open Access | Times Cited: 1087
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
Kizzmekia S. Corbett, Barbara J. Flynn, Kathryn E. Foulds, et al.
New England Journal of Medicine (2020) Vol. 383, Iss. 16, pp. 1544-1555
Open Access | Times Cited: 1045
Kizzmekia S. Corbett, Barbara J. Flynn, Kathryn E. Foulds, et al.
New England Journal of Medicine (2020) Vol. 383, Iss. 16, pp. 1544-1555
Open Access | Times Cited: 1045
A dynamic COVID-19 immune signature includes associations with poor prognosis
Adam G. Laing, Anna Lorenc, Irene del Molino del Barrio, et al.
Nature Medicine (2020) Vol. 26, Iss. 10, pp. 1623-1635
Open Access | Times Cited: 919
Adam G. Laing, Anna Lorenc, Irene del Molino del Barrio, et al.
Nature Medicine (2020) Vol. 26, Iss. 10, pp. 1623-1635
Open Access | Times Cited: 919
Aging in COVID-19: Vulnerability, immunity and intervention
Yiyin Chen, Sabra L. Klein, Brian T. Garibaldi, et al.
Ageing Research Reviews (2020) Vol. 65, pp. 101205-101205
Open Access | Times Cited: 909
Yiyin Chen, Sabra L. Klein, Brian T. Garibaldi, et al.
Ageing Research Reviews (2020) Vol. 65, pp. 101205-101205
Open Access | Times Cited: 909
T cell responses in patients with COVID-19
Zeyu Chen, E. John Wherry
Nature reviews. Immunology (2020) Vol. 20, Iss. 9, pp. 529-536
Open Access | Times Cited: 826
Zeyu Chen, E. John Wherry
Nature reviews. Immunology (2020) Vol. 20, Iss. 9, pp. 529-536
Open Access | Times Cited: 826
Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts
Jin Wang, Mengmeng Jiang, Xin Chen, et al.
Journal of Leukocyte Biology (2020) Vol. 108, Iss. 1, pp. 17-41
Open Access | Times Cited: 724
Jin Wang, Mengmeng Jiang, Xin Chen, et al.
Journal of Leukocyte Biology (2020) Vol. 108, Iss. 1, pp. 17-41
Open Access | Times Cited: 724
Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients
Anthony T. Tan, Martin Linster, Chee Wah Tan, et al.
Cell Reports (2021) Vol. 34, Iss. 6, pp. 108728-108728
Open Access | Times Cited: 692
Anthony T. Tan, Martin Linster, Chee Wah Tan, et al.
Cell Reports (2021) Vol. 34, Iss. 6, pp. 108728-108728
Open Access | Times Cited: 692
Immunity, endothelial injury and complement-induced coagulopathy in COVID-19
Luca Perico, Ariela Benigni, Federica Casiraghi, et al.
Nature Reviews Nephrology (2020) Vol. 17, Iss. 1, pp. 46-64
Open Access | Times Cited: 561
Luca Perico, Ariela Benigni, Federica Casiraghi, et al.
Nature Reviews Nephrology (2020) Vol. 17, Iss. 1, pp. 46-64
Open Access | Times Cited: 561
Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases
Alison Tarke, John Sidney, Conner K. Kidd, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 2, pp. 100204-100204
Open Access | Times Cited: 537
Alison Tarke, John Sidney, Conner K. Kidd, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 2, pp. 100204-100204
Open Access | Times Cited: 537
Immunological mechanisms of vaccine-induced protection against COVID-19 in humans
Manish Sadarangani, Arnaud Marchant, Tobias R. Kollmann
Nature reviews. Immunology (2021) Vol. 21, Iss. 8, pp. 475-484
Open Access | Times Cited: 532
Manish Sadarangani, Arnaud Marchant, Tobias R. Kollmann
Nature reviews. Immunology (2021) Vol. 21, Iss. 8, pp. 475-484
Open Access | Times Cited: 532
SARS-CoV-2 variants of concern partially escape humoral but not T cell responses in COVID-19 convalescent donors and vaccine recipients
Daryl Geers, Marc C. Shamier, Susanne Bogers, et al.
Science Immunology (2021) Vol. 6, Iss. 59
Open Access | Times Cited: 520
Daryl Geers, Marc C. Shamier, Susanne Bogers, et al.
Science Immunology (2021) Vol. 6, Iss. 59
Open Access | Times Cited: 520
Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum
Stuart P. Weisberg, Thomas J. Connors, Yun Zhu, et al.
Nature Immunology (2020) Vol. 22, Iss. 1, pp. 25-31
Open Access | Times Cited: 488
Stuart P. Weisberg, Thomas J. Connors, Yun Zhu, et al.
Nature Immunology (2020) Vol. 22, Iss. 1, pp. 25-31
Open Access | Times Cited: 488
Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19
Jennifer A. Juno, Hyon‐Xhi Tan, Wen Shi Lee, et al.
Nature Medicine (2020) Vol. 26, Iss. 9, pp. 1428-1434
Open Access | Times Cited: 435
Jennifer A. Juno, Hyon‐Xhi Tan, Wen Shi Lee, et al.
Nature Medicine (2020) Vol. 26, Iss. 9, pp. 1428-1434
Open Access | Times Cited: 435
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial
Raches Ella, Krishna Mohan Vadrevu, Harsh Jogdand, et al.
The Lancet Infectious Diseases (2021) Vol. 21, Iss. 5, pp. 637-646
Open Access | Times Cited: 422
Raches Ella, Krishna Mohan Vadrevu, Harsh Jogdand, et al.
The Lancet Infectious Diseases (2021) Vol. 21, Iss. 5, pp. 637-646
Open Access | Times Cited: 422
Divergent SARS-CoV-2 Omicron–reactive T and B cell responses in COVID-19 vaccine recipients
Corine H. GeurtsvanKessel, Daryl Geers, Katharina S. Schmitz, et al.
Science Immunology (2022) Vol. 7, Iss. 69
Open Access | Times Cited: 404
Corine H. GeurtsvanKessel, Daryl Geers, Katharina S. Schmitz, et al.
Science Immunology (2022) Vol. 7, Iss. 69
Open Access | Times Cited: 404
Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection
Jianmin Zuo, Alexander C. Dowell, Hayden Pearce, et al.
Nature Immunology (2021) Vol. 22, Iss. 5, pp. 620-626
Open Access | Times Cited: 387
Jianmin Zuo, Alexander C. Dowell, Hayden Pearce, et al.
Nature Immunology (2021) Vol. 22, Iss. 5, pp. 620-626
Open Access | Times Cited: 387
Pre-existing immunity to SARS-CoV-2: the knowns and unknowns
Alessandro Sette, Shane Crotty
Nature reviews. Immunology (2020) Vol. 20, Iss. 8, pp. 457-458
Open Access | Times Cited: 381
Alessandro Sette, Shane Crotty
Nature reviews. Immunology (2020) Vol. 20, Iss. 8, pp. 457-458
Open Access | Times Cited: 381
Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19
Adam K. Wheatley, Jennifer A. Juno, Jing Jing Wang, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 358
Adam K. Wheatley, Jennifer A. Juno, Jing Jing Wang, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 358